Scott Praill Insider Trading $KTRA Kintara Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott Praill.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Praill. Scott Praill is CFO in DelMar Pharmaceuticals, Inc. ($DMPI) and Chief Financial Officer in DelMar Pharmaceuticals, Inc. ($DMPI) and Chief Financial Officer in DelMar Pharmaceuticals, Inc. ($DMPI).
Scott Praill in Kintara Therapeutics, Inc.
Trading Symbol: KTRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott Praill: Chief Financial Officer, Chief Financial Officer, CFO
Holdings: 7,548 shares
Latest Transaction: Apr 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Scott Praill in Kintara Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | C | 0.00 | 3,750 | 0 | 0 | |
Apr 29 2021 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | C | 0.00 | 938 | 0 | 8,486 | 7.5 K to 8.5 K (+12.43 %) |
Apr 29 2021 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 8 | 0 | 7,548 | 7.5 K to 7.5 K (+0.11 %) |
Mar 31 2021 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,540 | 7.5 K to 7.5 K (+0.29 %) |
Jan 04 2021 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,518 | 7.5 K to 7.5 K (+0.29 %) |
Sep 30 2020 | KTRA | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,496 | 7.5 K to 7.5 K (+0.29 %) |
Sep 17 2020 | DMPI | Kintara Therapeuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | A | 1.70 | 606,557 | 1,031,147 | 606,557 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | A | 0.61 | 57,170 | 34,874 | 108,366 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,474 | 7.5 K to 7.5 K (+0.30 %) |
Mar 31 2020 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,452 | 7.4 K to 7.5 K (+0.30 %) |
Jan 02 2020 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,430 | 7.4 K to 7.4 K (+0.30 %) |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | A | 0.61 | 51,196 | 31,230 | 51,196 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | A | 0.61 | 57,170 | 34,874 | 57,170 | |
Jul 01 2019 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.00 | 22 | 0 | 7,386 | 7.4 K to 7.4 K (+0.30 %) |
Apr 01 2019 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.49 | 211 | 103 | 73,632 | 73.4 K to 73.6 K (+0.29 %) |
Jan 02 2019 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 0.34 | 211 | 72 | 73,421 | 73.2 K to 73.4 K (+0.29 %) |
Nov 13 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | A | 0.61 | 100,000 | 60,990 | 100,000 | |
Oct 01 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 73,210 | 73 K to 73.2 K (+0.29 %) |
Jul 03 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 72,999 | 72.8 K to 73 K (+0.29 %) |
Apr 03 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 72,788 | 72.6 K to 72.8 K (+0.29 %) |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Option Exercise | C | 0.00 | 25,000 | 0 | 0 | |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | C | 0.00 | 25,000 | 0 | 72,577 | 47.6 K to 72.6 K (+52.55 %) |
Jan 03 2018 | DMPI | DelMar Pharmaceuti ... | Praill Anthony Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 47,577 | 47.4 K to 47.6 K (+0.45 %) |
Oct 05 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Of ... | Buy | P | 0.85 | 17,500 | 14,910 | 47,366 | 29.9 K to 47.4 K (+58.60 %) |
Oct 02 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Of ... | Buy | J | 3.20 | 211 | 675 | 29,866 | 29.7 K to 29.9 K (+0.71 %) |
Jul 05 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 29,655 | 29.4 K to 29.7 K (+0.72 %) |
Jun 28 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Of ... | Buy | P | 3.60 | 4,167 | 15,001 | 29,444 | 25.3 K to 29.4 K (+16.49 %) |
Jun 06 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | P | 2.10 | 9,500 | 19,950 | 25,277 | 15.8 K to 25.3 K (+60.21 %) |
Apr 03 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Of ... | Buy | J | 3.20 | 211 | 675 | 15,777 | 15.6 K to 15.8 K (+1.36 %) |
Feb 22 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | CFO | Option Exercise | A | 4.95 | 37,400 | 185,130 | 37,400 | |
Jan 03 2017 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | J | 3.20 | 211 | 675 | 15,566 | 15.4 K to 15.6 K (+1.37 %) |
Oct 04 2016 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Of ... | Buy | J | 3.20 | 211 | 675 | 15,355 | 15.1 K to 15.4 K (+1.39 %) |
Jul 19 2016 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | J | 3.20 | 144 | 461 | 15,144 | 15 K to 15.1 K (+0.96 %) |
May 03 2016 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Option Exercise | P | 0.00 | 3,750 | 0 | 3,750 | |
Jul 16 2015 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Option Exercise | P | 0.75 | 50,000 | 37,500 | 50,000 | |
Jul 16 2015 | DMPI | DelMar Pharmaceuti ... | Praill Scott | Chief Financial Off ... | Buy | P | 0.60 | 50,000 | 30,000 | 60,000 | 10 K to 60 K (+500.00 %) |
Mar 20 2014 | DMPI | DelMar Pharmaceuti ... | Praill Scott | CFO | Buy | P | 1.30 | 10,000 | 13,000 | 10,000 | 0 to 10 K |
Aug 20 2013 | DMPI | DelMar Pharmaceuti ... | Praill Scott | CFO | Option Exercise | A | 1.05 | 350,000 | 367,500 | 350,000 |
Page: 1